Intercure Ltd. logo

Intercure Ltd. (INCR)

Market Closed
5 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
1. 36
+0.03
+2.26%
Pre Market
$
1. 41
+0.05 +3.68%
73.59M Market Cap
- P/E Ratio
0% Div Yield
1,864 Volume
- Eps
$ 1.33
Previous Close
Day Range
1.33 1.36
Year Range
1.22 1.79
Want to track INCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

INCR closed Friday higher at $1.36, an increase of 2.26% from Thursday's close, completing a monthly increase of 2.26% or $0.03. Over the past 12 months, INCR stock lost -15.53%.
INCR is not paying dividends to its shareholders.
The last earnings report, released on Nov 18, 2025, missed the consensus estimates by -0.05%. On average, the company has fell short of earnings expectations by -0.03%, based on the last three reports.
Intercure Ltd. has completed 1 stock splits, with the recent split occurring on Apr 08, 2021.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

INCR Chart

Similar

QSG
Here Group Limited
$ 5.41
+5.25%
NIU
Niu Technologies
$ 3.21
-8.02%
Microvision Inc.
$ 0.92
-0.65%
Alpha Teknova, Inc.
$ 4.8
-0.62%
Rci Hospitality Holdings Inc.
$ 26.02
-1.03%
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

InterCure Ltd. INCR has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates.

Benzinga | 1 year ago
InterCure: A Cannabis Industry Leader Still Flying Under The Radar

InterCure: A Cannabis Industry Leader Still Flying Under The Radar

InterCure is a leading pharmaceutical/medical cannabis company based in Israel and a global leader outside North America. Despite the damage the Hamas attack and the state of war in Israel caused, the company managed to sustain operations and present a positive 2023 ER. The company is entitled to full compensation from the Israeli government for the damage taken.

Seekingalpha | 1 year ago

Intercure Ltd. (INCR) FAQ

What is the stock price today?

The current price is $1.36.

On which exchange is it traded?

Intercure Ltd. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is INCR.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 73.59M.

Has Intercure Ltd. ever had a stock split?

Intercure Ltd. had 1 splits and the recent split was on Apr 08, 2021.

Intercure Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Alexander Rabinovich CEO
NASDAQ (NMS) Exchange
M549GJ111 CUSIP
IL Country
320 Employees
- Last Dividend
8 Apr 2021 Last Split
- IPO Date

Overview

InterCure Ltd. is a prominent player in the medical cannabis industry, extending its footprint beyond its home country Israel to serve international markets. Founded in 1994 and based in Herzliya, Israel, the company has carved a niche in researching, cultivating, producing, and distributing pharmaceutical-grade cannabis and cannabis-based products tailored for medical applications. Besides its core operations in the cannabis sector, InterCure Ltd. also places strategic investments in the biomed sector, reflecting its broader vision in healthcare and medical innovations.

Products and Services

  • Dried Cannabis Inflorescences: These are high-quality cannabis flowers cultivated under stringent controls to ensure pharmaceutical-grade quality. Used primarily for their therapeutic properties, they serve patients who rely on medical cannabis for relief from various conditions.
  • Cannabis Extract Mixed with Oil: This product combines potent cannabis extracts with carrier oils to enhance bioavailability and ease of use. It's designed for patients seeking precise dosage and a more convenient consumption method than traditional flower products.

Contact Information

Address: 85 Medinat ha-Yehudim Street
Phone: 972 7 7460 5012